Double Helix Added to New McCann Health Consultancy

Interpublic-owned marketing network McCann Health has launched a business called 'Consulting at McCann Health', which will offer market research through sister agency Double Helix, as well as services such as business strategy and development of digital solutions.

Pharma specialist Double Helix applies primary qual and quant market research throughout a product's lifecycle, and offers market access consulting / product positioning. The firm will now be integrated into the new 'Consulting at' business, which will have offices in New York, London and Tokyo, and be led by McCann Health's former Global Chief Business Strategy Officer Simon Holt (pictured), who joined in March from Novartis.

John Cahill, McCann Health Global CEO, comments: 'With Consulting at McCann Health, we add significant depth and breadth to our global strategic offering to provide clients with more innovative strategic counsel as they shift their approach from 'creating new molecules' to 'rewarding outcomes'. This shift will present significant opportunities for pharmaceutical companies to operate more as brands that promote improved wellbeing throughout people's lives, rather than as companies that market specific products'.

Web site: www.mccannhealth.com .